Meta-analysis of the association of Trp64 arg polymorphism of β3- adrenergic receptor gene with body mass index

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2441-2444

  Fujisawa, Tomomi ^a   Ikegami, Hiroshi ^a,b   Kawaguchi, Yoshihiko ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE;

ANALYSIS OF VARIANCE; ARGININE; BODY MASS INDEX; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; TRYPTOPHAN;

EID: 0031787748     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2441     Document Type: Article

References (40)

1. Moll PP, Burns TL, Lauer RM. 1991 The genetic and environmental sources of body mass index variability: the Muscatine Ponderosity Family Study. Am J Hum Genet. 49:1243-1255.
2. Carmelli D, Cardon LR, Fabsitz R. 1994 Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet. 55:566-573.
3. Perusse L, Chagnon YC, Dionne FT, Bouchant C. 1997 The human obesity gene map: the 1996 update. Obes Res. 5:49-61.
4. 3-adrenergic receptor: the search for a physiological function. Trends Pharmacol Sci. 15:3-7.
5. 3-adrenergic receptor: a cause and cure of obesity? N Engl J Med. 333:382-383.
6. 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet. 348:698-689.
7. 3-Adrenoceptor variant in obesity and insulin resistance. Lancet. 348:1584-1585.
8. 3-Adrenoceptor variant in obesity and insulin resistance. Lancet. 348:1585.
9. 3-adrenergic-receptor gene. N Engl J Med. 333:343-347.
10. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333:348-351.
11. 3-adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333:352-354.
12. Petitti DB. 1994 Meta-analysis decision analysis, and cost-effectiveness analysis. Oxford: Oxford University Press.
13. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 215:555-560.
14. 3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 346:1433-1344.
15. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 39:349-352.
16. 3-adrenergic-receptor in Japanese NIDDM patients. Diabetes Care. 19:271-272.
17. 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 39:857-860.
18. 3-adrenergic receptor gene. Diabetes. 45:1115-1120.
19. 3-adrenergic-receptor in Japanese NIDDM patients. Diabetes Care. 19:1034-1035.
20. 64Arg mutation is overrepresented in obese women: effects of weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes. 45:1358-1363.
21. 3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts. J Clin Invest. 98:2086-2093.
22. 3-adrenergic receptor gene with NIDDM, current and maximal body mass index. Diabetologia. 39:1410.
23. 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene. Diabetologia. 39:1505-1511.
24. 3-adrenergic receptor locus in obesity and non-insulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab. 81:4422-4427.
25. 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord 20:1055-1061.
26. Fumeron F, Durack BI, Betoulle D, et al. 1996 Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord. 20:1051-1054.
27. 3 adrenergic receptor in essential hypertension: insulin resistance and adrenergic system. Am J Hypertens. 10:101-105.
28. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes. 46:77-80.
29. 3-Adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia. 40:200-204.
30. 3-adrenergic receptor gene in Japanese subjects. Metabolism. 46:199-202.
31. 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophis Res Commun. 232:728-730.
32. 3,-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis J Clin Endocrnol Metab. 82:1284-1287.
33. 3-Adrenergic receptor gene polymorphism is not a malour genetic determinant of obesity and diabetes in Japanese general population. Diabetes Res Clin Pract. 37:1-7.
34. 3-adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care. 20:1319-1323.
35. 3-adrenergic receptor and insulin sensitivity in subjects with glucose intolerance. Intern Med. 36:606-609.
36. 3-adrenergic receptor does not relate to body weight in healthy, premenopousal women. Int J Obes Relat Metab Disord. 21:826-829.
37. 64Arg) in obese diabetic and non-diabetic subjects. Clin Exp Pharmcol Physiol. 24:733-735.
38. 3-adrenergic receptor gene related to non-insulin-dependent diabetes mellitus and juvenile hypertension in the Czech population? Ann NY Acad Sci. 827:135-143.
39. 3-Adrenoreceptor gene polymorphim: a newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes. 46:1633-1636.
40. 3-adrenoreceptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care. 20:1887-1890.